{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T19:01:38Z","timestamp":1783105298235,"version":"3.54.6"},"reference-count":44,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T00:00:00Z","timestamp":1746662400000},"content-version":"vor","delay-in-days":7,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK114006"],"award-info":[{"award-number":["DK114006"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK133203"],"award-info":[{"award-number":["DK133203"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003973","name":"Atlanta Neuroscience Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003973","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014468","name":"Mallinckrodt Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014468","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012569","name":"University of Toledo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012569","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.kint.2025.01.009","type":"journal-article","created":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T19:02:23Z","timestamp":1737658943000},"page":"835-851","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Melanocortin 5 receptor signaling protects against podocyte injury in proteinuric glomerulopathies"],"prefix":"10.1016","volume":"107","author":[{"given":"Bohan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengxuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyang","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Gunning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ragheb","family":"Assaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2471-5989","authenticated-orcid":false,"given":"Lance D.","family":"Dworkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying Jin","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rujun","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2025.01.009_bib1","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.1681\/ASN.2005090899","article-title":"Glomerular disease workshop","volume":"16","author":"Meyers","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2025.01.009_bib2","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1056\/NEJM198806233182505","article-title":"The progression of renal disease","volume":"318","author":"Klahr","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.kint.2025.01.009_bib3","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.kint.2021.05.021","article-title":"KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases","volume":"100","year":"2021","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2025.01.009_bib4","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S0025-7125(05)70538-1","article-title":"Diagnosis and management of glomerular diseases","volume":"81","author":"Jennette","year":"1997","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.kint.2025.01.009_bib5","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.mcna.2012.04.007","article-title":"Immunotherapy in renal diseases","volume":"96","author":"Kher","year":"2012","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.kint.2025.01.009_bib6","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nrneph.2009.108","article-title":"New insights into the role of podocytes in proteinuria","volume":"5","author":"Patrakka","year":"2009","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.kint.2025.01.009_bib7","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1038\/sj.ki.5000410","article-title":"The podocyte's response to injury: role in proteinuria and glomerulosclerosis","volume":"69","author":"Shankland","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2025.01.009_bib8","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/nrneph.2011.190","article-title":"The renaissance of corticotropin therapy in proteinuric nephropathies","volume":"8","author":"Gong","year":"2011","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.kint.2025.01.009_bib9","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1053\/j.ackd.2013.09.004","article-title":"Leveraging melanocortin pathways to treat glomerular diseases","volume":"21","author":"Gong","year":"2014","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1016\/j.kint.2025.01.009_bib10","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1042\/CS20200016","article-title":"Melanocortin therapy ameliorates podocytopathy and proteinuria in experimental focal segmental glomerulosclerosis involving a podocyte specific non-MC1R-mediated melanocortinergic signaling","volume":"134","author":"Qiao","year":"2020","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.kint.2025.01.009_bib11","doi-asserted-by":"crossref","DOI":"10.1038\/srep27589","article-title":"MC1R is dispensable for the proteinuria reducing and glomerular protective effect of melanocortin therapy","volume":"6","author":"Qiao","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.kint.2025.01.009_bib12","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.kint.2022.09.025","article-title":"Hematopoietic-specific melanocortin 1 receptor signaling protects against nephrotoxic serum nephritis and mediates the beneficial effect of melanocortin therapy","volume":"103","author":"Guan","year":"2023","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2025.01.009_bib13","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1681\/ASN.2022050605","article-title":"Negative modulation of B cell activation by melanocortin 1 receptor signaling protects against membranous nephropathy","volume":"34","author":"Chen","year":"2023","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2025.01.009_bib14","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1681\/ASN.2009101025","article-title":"Melanocortin 1 receptor agonists reduce proteinuria","volume":"21","author":"Lindskog","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2025.01.009_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-34004-7","article-title":"Amplification of the melanocortin-1 receptor in nephrotic syndrome identifies a target for podocyte cytoskeleton stabilization","volume":"8","author":"Bergwall","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.kint.2025.01.009_bib16","series-title":"Common Patterns of Glomerular Gene Expression Profiles in Different Murine Models of Early Nephropathy","author":"Blutke","year":"2008"},{"key":"10.1016\/j.kint.2025.01.009_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0081812","article-title":"A novel source of cultured podocytes","volume":"8","author":"Da Sacco","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.kint.2025.01.009_bib18","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/ki.2012.447","article-title":"Adrenocorticotropic hormone ameliorates acute kidney injury by steroidogenic-dependent and -independent mechanisms","volume":"83","author":"Si","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2025.01.009_bib19","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.kint.2020.05.052","article-title":"Global transcriptomic changes occur in aged mouse podocytes","volume":"98","author":"Wang","year":"2020","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2025.01.009_bib20","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.1007\/s00018-020-03511-0","article-title":"Melanocortin 5 receptor signaling pathway in health and disease","volume":"77","author":"Xu","year":"2020","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.kint.2025.01.009_bib21","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0092-8674(00)80467-5","article-title":"Exocrine gland dysfunction in MC5-R-deficient mice: evidence for coordinated regulation of exocrine gland function by melanocortin peptides","volume":"91","author":"Chen","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.kint.2025.01.009_bib22","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0014-2999(03)01322-0","article-title":"Characterization of aliphatic, cyclic, and aromatic N-terminally \"capped\" His-D-Phe-Arg-Trp-NH2 tetrapeptides at the melanocortin receptors","volume":"462","author":"Holder","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.kint.2025.01.009_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0212486","article-title":"Sexual dimorphism of acute doxorubicin-induced nephrotoxicity in C57Bl\/6 mice","volume":"14","author":"Grant","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.kint.2025.01.009_bib24","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1681\/ASN.20233411S1647b","article-title":"Multi-omics of sex-based differences in nephrotoxic serum nephritis","volume":"34","author":"Garcia","year":"2023","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2025.01.009_bib25","doi-asserted-by":"crossref","first-page":"701","DOI":"10.2353\/ajpath.2009.080606","article-title":"Adoptive transfer of syngeneic bone marrow-derived cells in mice with obesity-induced diabetes: selenoorganic antioxidant ebselen restores stem cell competence","volume":"174","author":"Chen","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1016\/j.kint.2025.01.009_bib26","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1165\/rcmb.2007-0224RC","article-title":"The prolonged life-span of alveolar macrophages","volume":"38","author":"Murphy","year":"2008","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.kint.2025.01.009_bib27","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/ki.2014.428","article-title":"Fine-tuning of NF\u03baB by glycogen synthase kinase 3\u03b2 directs the fate of glomerular podocytes upon injury","volume":"87","author":"Bao","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2025.01.009_bib28","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1172\/JCI32022","article-title":"Proteolytic processing of dynamin by cytoplasmic cathepsin L is a mechanism for proteinuric kidney disease","volume":"117","author":"Sever","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.kint.2025.01.009_bib29","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1172\/JCI20402","article-title":"Induction of B7-1 in podocytes is associated with nephrotic syndrome","volume":"113","author":"Reiser","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.kint.2025.01.009_bib30","doi-asserted-by":"crossref","first-page":"F85","DOI":"10.1152\/ajprenal.90642.2008","article-title":"The monocyte chemoattractant protein-1\/CCR2 loop, inducible by TGF-beta, increases podocyte motility and albumin permeability","volume":"297","author":"Lee","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.kint.2025.01.009_bib31","article-title":"Pharmacological melanocortin 5 receptor activation attenuates glomerular injury and proteinuria in rats with puromycin aminonucleoside nephrosis","volume":"13","author":"Chen","year":"2022","journal-title":"Front Physiol"},{"key":"10.1016\/j.kint.2025.01.009_bib32","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.4049\/jimmunol.1300182","article-title":"Both MC5r and A2Ar are required for protective regulatory immunity in the spleen of post-experimental autoimmune uveitis in mice","volume":"191","author":"Lee","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.kint.2025.01.009_bib33","first-page":"53","article-title":"Melanocortin 5 receptor and ocular immunity","volume":"52","author":"Taylor","year":"2006","journal-title":"Cell Mol Biol (Noisy-le-Grand)"},{"key":"10.1016\/j.kint.2025.01.009_bib34","first-page":"73","article-title":"Distribution of cDNA for melanocortin receptor subtypes in human tissues","volume":"38","author":"Chhajlani","year":"1996","journal-title":"Biochem Mol Biol Int"},{"key":"10.1016\/j.kint.2025.01.009_bib35","doi-asserted-by":"crossref","first-page":"3901","DOI":"10.1242\/jeb.035121","article-title":"Characterization of the sea bass melanocortin 5 receptor: a putative role in hepatic lipid metabolism","volume":"212","author":"Sanchez","year":"2009","journal-title":"J Exp Biol"},{"key":"10.1016\/j.kint.2025.01.009_bib36","doi-asserted-by":"crossref","first-page":"R560","DOI":"10.1152\/ajpregu.00279.2005","article-title":"Modulation by dietary sodium intake of melanocortin 3 receptor mRNA and protein abundance in the rat kidney","volume":"290","author":"Ni","year":"2006","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.kint.2025.01.009_bib37","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.3389\/fphys.2018.01475","article-title":"The melanocortin MC5R as a new target for treatment of high glucose-induced hypertrophy of the cardiac H9c2 cells","volume":"9","author":"Trotta","year":"2018","journal-title":"Front Physiol"},{"key":"10.1016\/j.kint.2025.01.009_bib38","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/7368389","article-title":"Activation of melanocortin receptors MC 1 and MC 5 attenuates retinal damage in experimental diabetic retinopathy","volume":"2016","author":"Rossi","year":"2016","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.kint.2025.01.009_bib39","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.tcm.2005.03.001","article-title":"The reperfusion injury salvage kinase pathway: a common target for both ischemic preconditioning and postconditioning","volume":"15","author":"Hausenloy","year":"2005","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.kint.2025.01.009_bib40","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/nm.3313","article-title":"AKT2 is essential to maintain podocyte viability and function during chronic kidney disease","volume":"19","author":"Canaud","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.kint.2025.01.009_bib41","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1053\/j.ajkd.2014.01.008","article-title":"The podocyte under stress: AKT2 to the rescue","volume":"63","author":"Swaminathan","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2025.01.009_bib42","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1016\/j.ajpath.2014.06.027","article-title":"Glycogen synthase kinase 3beta dictates podocyte motility and focal adhesion turnover by modulating paxillin activity: implications for the protective effect of low-dose lithium in podocytopathy","volume":"184","author":"Xu","year":"2014","journal-title":"Am J Pathol"},{"key":"10.1016\/j.kint.2025.01.009_bib43","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1681\/ASN.2015050565","article-title":"Genetic and pharmacologic targeting of glycogen synthase kinase 3beta reinforces the Nrf2 antioxidant defense against podocytopathy","volume":"27","author":"Zhou","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2025.01.009_bib44","article-title":"Bone marrow transplantation procedures in mice to study clonal hematopoiesis","volume":"171","author":"Park","year":"2021","journal-title":"J Vis Exp"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253825000675?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253825000675?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T04:25:20Z","timestamp":1777695920000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253825000675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S0085253825000675"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2025.01.009","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Melanocortin 5 receptor signaling protects against podocyte injury in proteinuric glomerulopathies","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2025.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2025.01.026","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}